Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Research on the Impact of Law on Public Health, Program Announcement 03049

---
identifier: "/us/fr/03-18955"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Research on the Impact of Law on Public Health, Program Announcement 03049"
title_number: 0
title_name: "Federal Register"
section_number: "03-18955"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Research on the Impact of Law on Public Health, Program Announcement 03049"
positive_law: false
currency: "2003-07-25"
last_updated: "2003-07-25"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "03-18955"
document_type: "notice"
publication_date: "2003-07-25"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "68 FR 44083"
fr_volume: 68
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Research on the Impact of Law on Public Health, Program Announcement 03049

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Research on the Impact of Law on Public Health, Program Announcement 03049.

*Times and Dates:* 1 p.m.-1:30 p.m., August 11, 2003 (Open). 1:30 p.m.-5 p.m., August 11, 2003 (Closed). 8:30 a.m.-4 p.m., August 12, 2003 (Closed).

*Place:* Sheraton Midtown Colony Square Hotel, 188 14th Street at Peachtree, Atlanta, GA 30361, Telephone 404.892.6000.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement 03049.

**FOR FURTHER INFORMATION CONTACT:**

Joan F. Karr, Ph.D., Scientific Review Administrator, Public Health Practice Program Office, CDC, 4770 Buford Highway, MS-K38, Atlanta, GA 30341, Telephone 770.488.2597.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: July 21, 2003.

Alvin Hall,

Director, Management Analysis and Services Office,  Centers for Disease Control and Prevention.